Power Injection
Power Injection
Accordion header
Exploratory surgery has become a relic of the past, thanks to the combination of power injection and state-of-the-art scanner technology. Radiologists employ power injection during imaging procedures that help them to diagnose:
- Stroke
- Heart disease
- Cancer
- Vascular disease
- Physical injury
- Digestive disorders
Accordion header
1. Tight "Bolus" of Contrast Media
Contrast can be concentrated in the area of interest during the scan, providing maximum enhancement and visualization in the final image without a lot of waste.
2. Precise Timing of Contrast-Media Delivery
Faster scanners, like some cardiac CT scanners, take images in less than 1 second and make precise timing absolutely critical.
3. Consistent, Reproducible, Patient-Specific Results
Power injectors deliver a consistent flow rate and volume from scan to scan, allowing physicians to easily customize injection protocols for specific studies and specific patients.
4. Time and Cost Savings
Automated features of Bayer's MEDRAD® power injection systems enable them to be part of a very efficient healthcare procedure that saves time and money.
Accordion header
Ongoing advances in power injection systems have ensured that the MEDRAD® name continues to be synonymous with high quality, reliability, and innovation. Not only was MEDRAD a pioneer with angiography, computed tomography (CT) and magnetic resonance (MR) power injectors, we continue to lead the industry with our innovative injectors today.
Related Content
Related Content
Any individuals depicted on this web page are actors and not actual health care providers or patients.
Patient Information listed on the Graphical User Interfaces are fictitious examples only and do not contain any actual patient data.
MRI images throughout this website are actual patient cases but all personal identifiers have been removed or otherwise anonymized. No personally identifiable information is shown.
You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
© 2020-2024 Bayer
BAYER, the Bayer Cross, MEDRAD Stellant, MEDRAD Centargo, MEDRAD MRXperion, MEDRAD Stellant FLEX, MEDRAD XDS, MEDRAD Veris, MEDRAD Stellant P3T, MEDRAD Spectris Solaris, MEDRAD Spectris, MEDRAD Mark 7 Arterion, MEDRAD Mark V ProVis, MEDRAD Intego, MEDRAD Avanta, MEDRAD Twist & Go, MEDRAD VFlow, Certegra P3T, MEDRAD FluiDots, MEDRAD Vistron, MEDRAD Envision, MEDRAD Certo, MEDRAD, Stellant, MRXperion, Stellant FLEX, Veris, Spectris Solaris, Spectris, Mark 7 Arterion, Mark V ProVis, Avanta, Envision, Twist & Go, VFlow, Radimetrics, Certegra, P3T, Seamlessly Smart, DirectCARE, PartnerCARE, VirtualCare, SelectCARE, TechCARE and Calantic are trademarks owned by and/or registered to Bayer in the U.S. and/or other countries.
Bayer HealthCare LLC 100 Bayer Boulevard, PO Box 915, Whippany, NJ 07981
Last update: November 2024